Physician

David Cannon, M.D.

According to 2025 Medicare claims, David Cannon, M.D. (NPI: 1891778387) practices internal medicine in the Lynchburg, VA market, with the plurality of this provider's patient population coming from Lynchburg City, VA. This provider's primary affiliated billing organization is PRIVIA MEDICAL GROUP, LLC (NPI: 1013042480; TIN: 202265068) and primary practice location at 24501-2115. Cannon is affiliated with the Privia Quality Network, LLC (ACO ID: A2057), participating under the MSSP model.

Cannon's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 635 traditional Medicare patients, billed 8,971 HCPCS/CPT codes, and received $267,984 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 9,306 prescription claims across 781 beneficiaries totaling $557,827 in drug costs, led by Eliquis (Apixaban). DME data shows 342 claims. Open Payments data shows 6 records totaling $204. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $406,303 to $557,827. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $16,441 and ending at $28,760.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	860	9,210	$237,490
2016	892	9,539	$233,247
2017	722	9,650	$208,105
2018	780	12,147	$248,029
2019	721	11,490	$267,228
2020	662	14,778	$291,016
2021	646	7,656	$269,372
2022	587	7,449	$254,495
2023	564	7,504	$245,140
2024	635	8,971	$267,984

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	524	8,207	$406,303
2016	547	7,724	$404,960
2017	545	7,934	$384,070
2018	649	8,334	$390,273
2019	651	9,729	$526,352
2020	643	9,594	$574,284
2021	652	8,969	$597,970
2022	646	8,589	$565,577
2023	617	8,636	$591,681
2024	781	9,306	$557,827

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	59	363	$13,992
2016	43	306	$8,950
2017	38	267	$6,534
2018	30	296	$7,385
2019	73	261	$6,118
2020	36	232	$4,487
2021	29	250	$7,433
2022	62	351	$11,562
2023	18	186	$7,927
2024	40	342	$23,407

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	536	1,175	$80
80061	Blood test, lipids (cholesterol and triglycerides)	502	830	$13
80053	Blood test, comprehensive group of blood chemicals	511	882	$10
36415	Insertion of needle into vein for collection of blood sample	519	954	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	506	872	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	75	5,300	$101,612
Januvia	Sitagliptin Phosphate	46	3,220	$58,571
Ozempic	Semaglutide	40	1,934	$56,003
Xarelto	Rivaroxaban	28	1,914	$35,755
Jardiance	Empagliflozin	17	1,230	$22,727

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	33	$13,634
K0823	Power wheelchair, group 2 standard, captains chair, patient weight capacity up to and including 300 pounds	Y	N/R	12	$1,714
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	N/R	26	$1,343
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	36	$1,183
A7032	Cushion for use on nasal mask interface, replacement only, each	N	N/R	13	$1,062

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$204	InSightec,Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David Cannon, M.D.?

Tedicare shows public-source Medicare data for David Cannon, M.D. (NPI 1891778387), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Cannon, M.D. have ACO affiliation data?

David Cannon, M.D. is shown with ACO affiliation data for Privia Quality Network, LLC (MSSP, ACO ID A2057).

What billing organization is linked to David Cannon, M.D.?

David Cannon, M.D. is linked to PRIVIA MEDICAL GROUP, LLC (billing NPI 1013042480) in the available physician profile data.

Does David Cannon, M.D. have Open Payments data?

David Cannon, M.D. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.